Results

Total Results: 668 records

Showing results for "prescription".

221. White Paper: Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
     August 01, 2024 - Non-specific Low Back Pain VER-01; Opioid Therapy 350 March 2025 Evaluation of Medical Cannabis and Prescription … Reduction of Pain and Opioid Dose in Patients with Chronic Non-Cancer Pain Medical Marijuana; Prescription … Abbreviations: CBD = cannabidiol; MIRE = Monochromatic Infrared Photo Energy; NR = not reported; POTS = Prescription

222. White Paper: Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper.pdf
     July 01, 2023 - Non-specific Low Back Pain VER-01; Opioid Therapy 350 March 2025 Evaluation of Medical Cannabis and Prescription … Reduction of Pain and Opioid Dose in Patients with Chronic Non-Cancer Pain Medical Marijuana; Prescription … Abbreviations: CBD = cannabidiol; MIRE = Monochromatic Infrared Photo Energy; NR = not reported; POTS = Prescription

223. Computerized Definitions Showed High Positive Predictive Values for Identifying Reasons for Hospitalizations in a Medicaid Population with Rheumatoid Arthritis | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-hospitalizations/research
     October 30, 2008 - hospitalization discharge diagnosis of RA; one ambulatory visit that resulted in a diagnosis of RA and a prescription … Cohort members were required to have at least one prescription filled during baseline to assure access

224. Technical Brief – Wheeled Mobility (Wheelchair) Service Delivery | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/wheelchair-service/research-protocol
     July 01, 2010 - described key steps in wheeled mobility service delivery: a) referral and appointment, b) assessment, c) prescription … assessment (i.e., diagnosis vs. functional abilities, cognitive abilities, physical abilities) Assessment, prescription

225. Cannabis-App-F5-Table-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2.xlsx
     January 22, 2022 - 29.1 to ˗7.2) Overall absolute effect after medical cannabis authorization: ˗76.5 (˗308.0 to 154.9) Prescription

226. Appendix-E-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5.xlsx
     November 04, 2021 - 29.1 to ˗7.2) Overall absolute effect after medical cannabis authorization: ˗76.5 (˗308.0 to 154.9) Prescription

227. Cannabis-App-F5-Table-Surveillance-Report-2 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0.xlsx
     February 16, 2022 - 29.1 to ˗7.2) Overall absolute effect after medical cannabis authorization: ˗76.5 (˗308.0 to 154.9) Prescription

228. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
     February 16, 2022 - 29.1 to ˗7.2) Overall absolute effect after medical cannabis authorization: ˗76.5 (˗308.0 to 154.9) Prescription

229. Appendix-E-Table-E5 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
     November 04, 2021 - 29.1 to ˗7.2) Overall absolute effect after medical cannabis authorization: ˗76.5 (˗308.0 to 154.9) Prescription

230. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
     May 01, 2012 - As part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress directed … rates of identification and treatment for people with ADHD have increased in recent years;2-4 however, prescription … girls and older children consistent with changes in clinical guidelines.3,8 Increases in off- label prescription … Information about clinical identification and treatment (available through administrative and prescription … Prescription of methylphenidate to children and youth, 1990-1996.

231. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - clinical effectiveness, safety, and appropriateness of health care items and services, particularly prescription … important to include in the propensity score, most likely the closest in time prior to the date of the prescription … For example, a prescription for a lipid lowering agent or a hospitalization with a diagnosis of angina … dL) 180.66 155.08 <0.0001 Triglyceride level (mg/dL) 202.66 166.91 <0.0001 Cardiovascular-related prescription … mg/dL) 177.84 177.58 0.7837 Triglyceride level (mg/dL) 200.34 200.50 0.9626 Cardiovascular-related prescription

232. Pregnancy and Medicines | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/pregnancy-and-medicines
     January 11, 2019 - Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions Research Protocol January 11, 2019 Management of Primary Headaches in Pregnancy Systematic Review November 12, 2020

233. Wheelchair-Service Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_research-protocol.pdf
     July 01, 2010 - described key steps in wheeled mobility service delivery: a) referral and appointment, b) assessment, c) prescription … Assessment, prescription, and delivery steps (i.e., access, number of visits covered by insurance,

234. Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
     October 05, 2012 - that were considered distinct included duration of antibiotic therapy in days, rate of antibiotic prescription … Meta-analyses have been added for antibiotic duration, antibiotic prescription rate, short-term mortality … 2006, 54% of ambulatory visits for an acute respiratory tract infection resulted in an antibiotic prescription … Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

235. Payer Perspectives on Improving Usability of Effective Health Care Products: Bridging the Gap Between Information Needs and Evidence Translation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/payer-usability/white-paper
     February 03, 2014 - Section 1013 of the 2003 Medicare Prescription Drug, Improvement, and Modernization Act, which instructed

236. Presentation of Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/presentations-future_research.pdf
     April 01, 2012 - Presentation of Future Research Needs ii Methods Future Research Needs Report Number 9 Presentation of Future Research Needs Methods Future Research Needs Report Number 9 Presentation of Future Research…

237. The AHRQ Evidence-Based Care (EBC) Challenge | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/get-involved/research
     June 01, 2013 - Creativity: The judging panel appreciated the PAWS (Prescription for Antibiotics or Wait and See) acronym

238. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - -based, online aggregator of prescription-drug prices, a 30-day supply of nintedanib (150 mg) costs … -based, online aggregator of prescription-drug prices, GoodRx, a monthly supply of ivacaftor costs … Ofev (nintedanib) capsules - prescription reimbursement support. [internet]. … Available: https://www.ofev.com/prescription-savings. 36. … Aetna non-Medicare prescription drug plan. Subject: idiopathic pulmonary fibrosis. [internet].

239. Appendixes A-I: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
     April 01, 2022 - Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People … Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial … Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in … Perceived Efficacy, Reduced Prescription Drug Use, and Minimal Side Effects of Cannabis in Patients … Risk and benefit of cannabis prescription for chronic non-cancer pain.

240. Summary Variables in Observational Research: Propensity Scores and Disease Risk Scores | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/observational-research-scores/research
     May 15, 2012 - important to include in the propensity score, most likely the closest in time prior to the date of the prescription … For example, a prescription for a lipid lowering agent or a hospitalization with a diagnosis of angina … 155.08 <0.0001 Triglyceride level (mg/dL) 202.66 166.91 <0.0001 Cardiovascular-related prescription … 2901 Non-Initiators N=2901 P-Value Lipid-related labs 24.90 24.64 0.4987 Different prescription … 177.58 0.7837 Triglyceride level (mg/dL) 200.34 200.50 0.9626 Cardiovascular-related prescription